AbbVie (ABBV) stock is in focus as a kidney disease therapy developed by the company and its partner Calico wins the FDA Fast Track Designation. Read more here.
Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental ...
When University of Texas at Arlington researcher Paul J. Fadel and his colleagues launched a study on vascular health in ...
Cystatin C is an emerging biomarker that enhances kidney function assessment accuracy, particularly in hospitalized patients ...
Renalytix ( ($GB:RENX) ) has issued an update. Renalytix has submitted an application for CE Mark certification for its kidneyintelX.dkd test ...
Using biochemical markers such as estimated glomerular filtration rate (eGFR) and proteinuria improved precision, reaching ...
Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about its risk factors—and why there's new reason to hope for more effective ...
Surgical face masks help prevent the spread of airborne pathogens and therefore were ubiquitous during the Covid-19 pandemic. Now, a modified mask could also protect a wearer by detecting health ...
Kidneys play a vital role in keeping the body balanced and healthy. They remove waste, control fluid levels, manage blood pressure, and help produce important hormones. But kidney problems often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback